Life changing treatments are now available for incontinence, intimacy issues and menopausal symptoms.
Incontinence and GSM of menopause are NOT a normal part a women’s life and are not something you should have to live with. Inconteninence and GSM are real medical conditions that deserve treatment.
TREATMENTS AVAILABLE
V Tone
- Up to 6 treatments
- 1-3 weekly depending on response
Forma V
- 2-3 sessions
- 2-4 weekly, depending on response
- Maintenance: may need single treatment every 3-12 months with gradually increasing spacing
Morpheus 8V
- 2-3 treatments
- 3-4 weekly
- Maintenance: may need single treatment every 3-12 months with gradually increasing spacing
Do you suffer from?
- Vaginal Dryness (Vaginal Atrophy)
- Stress Urinary Incontinence (SUI)
- Urge Incontinence or Leaking
- Overactive Bladder or Urinary Frequency
- Interrupted Sleep from Multiple Trips to the Bathroom
- Painful Intercourse or Sexual Dysfunction
- Chronic or Recurrent UTI
- Recurrent Vaginal Infections (Yeast or Bacterial)
- Lichen Sclerosis
- Vaginal Laxity or Reduced Elasticity
- Pelvic Floor Weakness
- Decreased Vaginal Sensation or Decreased Ability to Achieve Orgasm
- Vulvar or Vaginal Pain
- Episiotomy Pain
- Labial Laxity, Redundant or Crepey Vulvar Skin or Labia
- Displeasure or Lack of Confidence in Vaginal/Vulvar Appearance
- Burning or Itching with Menopause
Did you check even one of the above?
If so, then you could be a candidate for Emsella or Empower RF treatments which are safe and effective. This innovative technology can make significant improvements and a real difference to your quality of life. This treatment is available at Natural Looks Cosmetic Medicine Clinic, book an appointment for an assessment and plan to get started.
Fig 2. Emsella Efficiency in comparison to kegel exercise.
MORPHEUS8 CASE STUDY
Safety, Tolerability and Short-Term Efficacy of Transvaginal Fractional Bipolar Radiofrequency Therapy for Symptoms of Stress and or Mixed Incontinence in conjunction with Genitourinary Syndrome of Menopause Tracy A. Blusewicz, MD, (FACOG), Katherine P. Coley, MD, (FACOG), Mickey Karram, MD, (FPMRS)
Introduction: Radiofrequency energy has been utilized to treat conditions such as vaginal laxity, atrophy, and stress urinary incontinence (SUI). Contact RF energy heats the mucosal surface of the vagina uniformly to deliver electrothermal energy to the connective tissues in the vaginal wall. This RF energy application stimulates collagen and elastin remodeling to restore the rigidity, elasticity, and moisture of the superficial vaginal mucosa. The limitation of this surface treatment is in the penetration depth of the energy to the vaginal tissue layers. This is the first study to report on the use of microneedling to deliver RF energy to the vaginal canal similar to what has been used to treat the skin surface of the face, neck, and chest. Microneedling increases the response of the collagen contraction and neocollagenesis in deeper layers of tissue, thus increasing the support to the surface. The novel intravaginal microneedling device used in this study allows penetration of the needles to 1 mm, 2 mm, or 3 mm.
Objective: A prospective pilot study to evaluate the outcome of a single fractional RF treatment of the vaginal canal in a series of women with coexistent stress or mixed incontinence (MUI) and genitourinary syndrome of menopause (GSM).
Methods: Twenty women who had symptoms of SUI and or MUI in conjunction with GSM were given a single vaginal treatment that consisted of fractional bipolar RF energy using the EmpowerRF platform with the Morpheus 8V applicator (InMode). RF energy was delivered into the vaginal walls via 24 microneedles, at a depth of 1 mm, 2 mm, and 3 mm. Outcomes were evaluated by “cough” stress test, questionnaires (MESA SI, MESA UI, iQoL, UDI-6) and evaluation of vaginal tissue through the VHI scale at 1-month, 3-months, and 6-months post-treatment compared to baseline. Biopsies were performed at baseline and 3-months on 5 patients for histological reference and tissue evaluation.
Results: Eight out of eight outcomes measured from baseline to 6-months post-treatment showed improvement. The parameters scored in the questionnaires including frequency,urgency, nocturia, urge incontinence, and stress incontinence showed significant improvement in all areas at the 1-month, 3-month, and 6-month follow-up sessions compared to baseline.
Conclusions: The results showed significant evidence that fractional RF energy delivered vaginally is safe, well tolerated, and helps treat symptoms of SUI and or MUI in conjunction with GSM.
Histological Results
Histological biopsies of the vaginal mucosa at 3- months post-treatment demonstrate an increase in elastic fibers density compared to the baseline biopsy. Both superficial and deep elastic fibers are seen. The biopsies also find nodamage to the submucosal collagen layer and no scar tissue formation in post-treatment, verifying no adverse effect of the fractional RF treatment.Figure 2 shows biopsies performed prior to treatment and at 3-months post treatment stained
with elastic and Ki-67 stains.
Figure 2. Histological section of skin biopsies before (Left) and 3-months following fractional treatment (Right) demonstrating increase in elastic fibers density. Up - Elastic x10, bottom – Ki-67x4.